Tofacitinib Ointment 2% w/w is a topical formulation containing 2% w/w of Tofacitinib, a Janus kinase (JAK) inhibitor. It is primarily used for the treatment of moderate to severe atopic dermatitis (eczema) in adults and adolescents. The ointment works by inhibiting specific enzymes involved in the immune response, reducing inflammation, redness, and itching associated with chronic skin conditions. Its non-steroidal mechanism makes it suitable for long-term management of eczema with a lower risk of skin thinning compared to corticosteroids. The formulation is designed for easy absorption, providing targeted relief directly at the site of inflammation.
